Agenus (AGEN) Capital Expenditures Growth (3y) (2013 - 2025)
Agenus (AGEN) Capital Expenditures Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn | 16.27% |
| 10 | Agenus | 228.40 Mn | 193.41 Mn | 33.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -94.50% |
| Mar 31, 2025 | -89.68% |
| Dec 31, 2024 | -66.15% |
| Sep 30, 2024 | -80.97% |
| Jun 30, 2024 | -41.22% |
| Mar 31, 2024 | -43.69% |
| Dec 31, 2023 | -35.58% |
| Sep 30, 2023 | 58.31% |
| Jun 30, 2023 | 43.04% |
| Mar 31, 2023 | 95.64% |
| Dec 31, 2022 | -79.21% |
| Sep 30, 2022 | -37.06% |
| Jun 30, 2022 | 84.75% |
| Mar 31, 2022 | 44.66% |
| Dec 31, 2021 | -18.49% |
| Sep 30, 2021 | 51.66% |
| Jun 30, 2021 | 74.19% |
| Mar 31, 2021 | -49.20% |
| Dec 31, 2020 | 37.44% |
| Sep 30, 2020 | -24.36% |